Enjamb (YC P26) Launches an AI Workforce Spanning the Full Drug Program
ycombinator · x · 2026-09-07
Enjamb (YC P26) claims to be the first AI workforce built to work across an entire drug program, unifying biopharma's fragmented work across scientific systems, clinical platforms, regulatory documents, quality records, and years of institutional knowledge.
More from Venture
- Anthropic's S-1 spans 400 pages with a sample-record 94-page risk section — nbaschez · 2026-10-26
- SpaceX strikes $40B deal with Apollo Global to lease AI chips and data center hardware — Polymarket · 2026-10-26
- Meta plans up to $95 billion stock sale to fund AI buildout — The Decoder · 2026-10-26
- Anthropic files S-1 with an all-time great risk factor, traders note — austinc3301 · 2026-10-26
- Anthropic posts $3.4B positive free cash flow in first half of 2026 — BenBajarin · 2026-10-26
- Polymarket puts 44% odds on Anthropic IPO closing above $2T market cap — Polymarket · 2026-10-26